Home LiteratureArticle Details
PMID: 4390958 Published · ppublish English Clinical Trial Comparative Study Controlled Clinical Trial Journal Article

Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.

British medical journal ·Vol. 4 ·No. 5680 ·1969-11-15 ·Pages 399-401

Wilson AG, Brooke OG, Lloyd HJ, Robinson BF

Abstract

The effect on exercise tolerance of racemic propranolol has been assessed in eight angina pectoris patients and compared with that of dexpropranolol (the dextro isomer of propranolol), practolol (I.C.I. 50172), and saline. Dexpropranolol has the same local anaesthetic action as propranolol with negligible beta-adrenergic receptor blocking activity, while practolol is a cardio-selective beta-adrenergic blocking agent which does not have local anaesthetic activity.Saline and dexpropranolol had no significant effect on exercise time; racemic propranolol and practolol improved exercise tolerance in six subjects, the response to the two drugs being very similar in individual patients. It was concluded that the beneficial effect of propranolol in angina pectoris results from its action as a beta-adrenergic receptor blocking agent and is not due to its local anaesthetic, or quinidine-like, activity.

MeSH Terms
Acetanilides/therapeutic use Adrenergic beta-Antagonists/therapeutic use Anesthesia, Local Angina Pectoris/drug therapy Clinical Trials as Topic Female Heart Function Tests Humans Male Physical Exertion Placebos Propranolol/therapeutic use Quinidine Stereoisomerism Sympatholytics/therapeutic use
Chemicals
Acetanilides Adrenergic beta-Antagonists Placebos Sympatholytics Propranolol Quinidine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wilson A G
Brooke O G
Lloyd H J
Robinson B F
References (14)
14 references, click to expand
  1. Effects of propranolol on exercise tolerance in angina pectoris.
    Am J Cardiol. 1966 Sep;18(3):354-60 PMID: 5922885
  2. Multicenter trial of propranolol in angina pectoris.
    Am J Cardiol. 1966 Sep;18(3):361-5 PMID: 4958811
  3. The prophylactic value of propranolol in angina pectoris.
    Am J Cardiol. 1966 Sep;18(3):370-83 PMID: 4958813
  4. The treatment of angina pectoris with a new beta-receptor blocking agent (H 56/28).
    Acta Med Scand. 1967 Sep;182(3):285-91 PMID: 4862333
  5. Propranolol in patients with angina pectoris.
    Ann Intern Med. 1967 Dec;67(6):1216-25 PMID: 4964853
  6. Selective blockade of adrenoceptive beta receptors in the heart.
    Br J Pharmacol Chemother. 1968 Jan;32(1):201-18 PMID: 4384337
  7. Clinical evaluation of verapamil in angina pectoris.
    Br Med J. 1968 Jul 27;3(5612):224-7 PMID: 4969551
  8. Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic acitivity in patients with angina pectoris.
    Circulation. 1969 Feb;39(2):157-69 PMID: 4884575
  9. Treatment of angina pectoris with beta-receptor blockade, mode of action.
    Acta Med Scand. 1968 Oct;184(4):259-62 PMID: 4974645
  10. Trasicor in angina pectoris: a double-blind trial.
    Br Med J. 1969 Apr 19;2(5650):155-7 PMID: 4976123
  11. Effects of a cardio-selective beta-adrenergic blocker (I.C.I. 50172) at exercise in angina pectoris.
    Br Med J. 1969 Jun 7;2(5657):601-3 PMID: 5798470
  12. EFFECT OF PRONETHALOL IN ANGINA PECTORIS.
    Br Med J. 1963 Nov 16;2(5367):1226-9 PMID: 14056892
  13. DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS.
    Br Med J. 1965 Apr 3;1(5439):897-8 PMID: 14257402
  14. USE OF PROPRANOLOL IN ANGINA PECTORIS.
    Br Med J. 1965 Aug 7;2(5457):337-9 PMID: 14314452
Article Info
Journal
British medical journal
Abbr.
Br Med J
ISSN
0007-1447
Published
1969-11-15
Pages
399-401
Language
English
Region
England
NLM ID
0372673
PMCID
PMC1629770
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com